申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0328834A1
公开(公告)日:1989-08-23
This invention relates to halogenated derivatives of certain phosphonates having the ability to inhibit aspartate transcarbamylase and therefore are useful in the treatment of certain cancers.
这项发明涉及具有抑制
天冬氨酸转
氨甲酰酶能力的某些
膦酸酯的卤代衍
生物,因此在治疗某些癌症方面具有用处。